Actuate Therapeutics

Last updated: April 15, 2024

Dan Schmitt, President and CEO
Dan Schmitt, President and CEO
Country: USA | Funding: $65M (+)

Website: https://actuatetherapeutics.com/

Actuate Therapeutics is a biopharmaceutical company focused on the development of compounds for use in the treatment of cancer, and inflammatory diseases leading to fibrosis and neurodegeneration. Our work has led to some fascinating results around anti-tumor activity in the brain, pancreas, lungs, and breasts.